• Huron Companies
    • Innosight
    • Studer Education
  • Subscribe to Huron Insights
  • Submit RFP
  • Careers
  • Contact Us
  • About Us
  • Favorites
  • Expertise
    • Business Operations
    • Care Transformation
    • Consumer Transformation
    • Digital, Technology & Analytics
    • Organizational Transformation
    • Research Enterprise
    • Strategy & Innovation
    • Upcoming Huron Events

      View Events
  • Industry
    • Education
    • Energy & Utilities
    • Financial Services
    • Healthcare
    • Industrials & Manufacturing
    • Life Sciences
    • Public Sector
    • See All
    • Simplify the stimulus benefits process

      Find Your Funding
  • Our Experts
    • View All Expert Bios
    • Find an expert specialized in your industry

      Book a Speaker
  • Insights
    • Articles
    • Case Studies
    • Research
    • View All Insights
    • Get the latest insights and updates from our experts

      Stay Connected
  • Expertise
    Expertise
    Business OperationsCare TransformationConsumer TransformationDigital, Technology & AnalyticsOrganizational TransformationResearch EnterpriseStrategy & Innovation

    Upcoming Huron Events

    View Events
  • Industry
    Industry
    EducationEnergy & UtilitiesFinancial ServicesHealthcareIndustrials & ManufacturingLife SciencesPublic SectorSee All

    Simplify the stimulus benefits process

    Find Your Funding
  • Our Experts
    Our Experts
    View All Expert Bios

    Find an expert specialized in your industry

    Book a Speaker
  • Insights
    Insights
    ArticlesCase StudiesResearchView All Insights

    Get the latest insights and updates from our experts

    Stay Connected
  • Careers
    Careers
    Join Our Talent CommunitySearch Open PositionsBenefits
  • About Huron
    About Huron
    The Huron DifferenceOur People & ValuesMaking an ImpactOur ResultsInvestor RelationsLocations
  • Help & Support
    Help & Support
    Contact UsSubmit an RFPBook a Speaker
  • Privacy
    Privacy
    Privacy StatementTerms & ConditionsCookies PolicyFraudulent OffersLabor Condition Applications
  • Favorites
    Recent Favorites
    You have no saved content.

Launch Excellence: Why So Elusive?

Favorite Bookmark

Doug Pfaff

Download Email Subscribe Print

New product launches have always been high stakes initiatives for pharmaceutical and medical device manufacturers. Today, the cumulative effect of increasingly innovative competitors, looming patent cliffs and shrinking windows of time to capture returns has amplified the pressure for successful launches.

Financial investment alone doesn’t guarantee results. Despite the significant budgets allocated to new product launches, most still fall short of forecasted revenues. As disruption continues to reshape the market, drug and medical device organizations need to understand and address the underlying factors that promote launch excellence.

To understand how teams approach the launch process and identify what drives success, Huron surveyed more than 50 cross-functional pharmaceutical professionals, over half of which have been involved in more than five launches in the last decade. Respondents’ feedback reveals distinct opportunities to elevate traditional launch tactics and improve outcomes.

Building a Strong Foundation for Launch Success

 A simple bar chart shows that 65% of launches are very or extremely successful and 33% are moderately successfulSixty-five percent of respondents rate their last three launches as “very” or “extremely” successful, with one-third reporting “moderately” successful launches. These findings are somewhat contradictory to industry benchmarks, suggesting that launch teams may judge their own achievement in ways beyond the forecast. Notably, respondents from affiliate operations report higher levels of success than those at the global level (83 percent vs. 57 percent respectively answered “very/extremely successful”). This difference highlights an apparent advantage of planning the more targeted, localized launches.

Survey results highlighted that launch success depends on effective execution of critical planning steps, including:

    A bar chart showing that confidence in market insights is greatest among respondents who report higher than average launch success
  • Comprehensive market insights. Ninety-one percent of all respondents agree that their teams develop and share robust market insights. Confidence in these insights, however, is greatest among respondents who report higher than average launch success.

    As the life sciences industry transforms, the importance of high quality market research cannot be understated. Capturing data around not only consumer and provider behavior, but also payer and caregiver needs, is essential to effective launch planning.
  • Alignment between launch and corporate priorities. Teams who plan within the context of a long-term corporate vision are more likely to show positive results. Unfortunately, pressure to meet shareholder expectations and create new growth often fosters a sense of tunnel vision around individual launches, leading to a lack of alignment with the broader corporate and portfolio strategies.

    Fissures between product and enterprise-wide plans can disrupt not only the current launch, but also marketed products and future launches. Resource allocation and other investment decisions made in isolation can be misinformed.

    Notably, respondents who work in market access are five times more likely than those in marketing to disagree with statements around strategic launch priorities. This may shed light on a key factor for a successful product launch: elevating market access teams’ involvement in strategic planning. 
A bar chart showing how respondents answered questions about having the right strategic priorities

The Impact of Agile, Collaborative Launch Processes

Assembling the right resources, team and timelines plays an outsized role in executing successful launches. However, a significant portion of the pharmaceutical professionals surveyed experience deficiencies in each of these areas. Misjudged timelines, miscalculated bandwidth and inflexible processes continue to plague launch efforts.

A bar chart of how respondents answered questions about the effectiveness of launch processes

  • Flexibility. As consumer needs and market threats evolve more rapidly, organizations need to ensure their launch approach is designed with agility in mind. Pharmaceutical professionals who rate recent launches as very or extremely successful are almost four times more likely to feel their organizations are nimble in the face of change.
  • Cross-team communication. Survey respondents who report above average launch success are more likely to proactively coordinate tactics and budgets across their organizations. The core launch team must integrate launch resource needs into each functional area’s plans and budgets and prioritize collaboration between global and affiliate teams.
  • Marketing and market access engagement. Compared to colleagues in medical affairs, analytics and clinical roles, market access and marketing professionals are less optimistic about having the resources and role clarity needed to execute a successful launch. Given marketing and market access groups’ broader roles in supporting a launch, they’re more likely to bear the brunt of ineffective processes. Equipping these teams with the right tools, and communicating their responsibilities well before a launch, is vital to keeping initiatives on time and on budget.

Bar charts showing how different groups answered questions about the effectiveness of processes, resources and training to drive execution

Launch Playbooks: An Iterative Process

A simple bar chart showing how respondents answered how well best practices are applied across multiple launchesThe ability to learn from past launches and embed best practices into a repeatable model, while obviously valuable, represents an ongoing challenge for pharmaceutical organizations. Only around one-quarter of respondents think their companies excel in this area.

Organizations are likely recreating the wheel (for at least portions of the launch process) for each new product, elevating the likelihood of inconsistencies and inefficiencies. An enterprise-level launch framework can address many of the core issues that hamper these efforts in the first place. Such a launch playbook isn’t immutable, but rather something to regularly revisit as market trends and internal capabilities evolve.

Making Launch Success Less Elusive

Product launches are inherently optimistic occasions for companies, representing opportunities to generate new sources of revenue and engage new customers. However, reality often falls short of expectations.

To combat new competitive threats and escalating financial obstacles, pharmaceutical leaders have an imperative to reassess the traditional launch approach. Organizations that proactively align product and portfolio strategies, develop more nimble processes, and simplify cross-functional collaboration can begin to flip the odds of launch success.

KEY TAKEAWAYS

Overcoming the barriers to an effective product launch requires life sciences organizations to:

Think differently.

Define the role each launch plays within the broader corporate and/or portfolio strategies, rather than treating each rollout as an isolated event.

Plan differently.

Design launch processes that increase your team's flexibility to adapt to market or timeline changes.

Act differently.

Develop an enterprise-wide, dynamic launch model and foster a culture that values continuous improvement around launch practices.

Favorite Bookmark
JS Inject Download Email Subscribe Print
Strategy and Innovation Life Sciences Article

Launch Excellence: Why So Elusive?

  • Doug Pfaff - July 2020 FINAL

    Doug Pfaff

    Managing Director

    Contact This Expert Read My Bio

Related Work

  • Navigating Market Access for Cell and Gene Therapy

    Read More

    A substantial number of cell and gene therapies delivering a cure or at least durable health benefits, are expected to be approved over the next 5 to 10 years.

View All

Subscribe

Receive the latest insights and news from Huron’s transformation experts.

We use cookies on our website to provide you with a more personalized digital experience, enable website functionality and understand the performance of our site. You may review our Privacy Statement and our Cookies Policy. By using this site you agree to our use of cookies. I Accept

  • Expertise
    • Business Operations
    • Care Transformation
    • Consumer Transformation
    • Digital, Technology & Analytics
    • Organizational Transformation
    • Research Enterprise
    • Strategy & Innovation
  • Industry
    • Education
    • Energy & Utilities
    • Financial Services
    • Healthcare
    • Industrials & Manufacturing
    • Life Sciences
    • Public Sector
  • About Huron
    • The Huron Difference
    • Our People & Values
    • Making an Impact
    • Our Results
    • Investor Relations
    • Locations
  • Help & Support
    • Contact Us
    • Submit an RFP
  • Careers
    • Search Open Positions
    • Join Our Talent Community
    • Benefits
  • Legal
    • Privacy Statement
    • Terms & Conditions
    • Cookies
    • Fraudulent Offers
    • Labor Condition Applications
  • Instagram

© 2021 Huron Consulting Group Inc. and affiliates. Huron is a global consultancy and not a CPA firm, and does not provide attest services, audits, or other engagements in accordance with standards established by the AICPA or auditing standards promulgated by the Public Company Accounting Oversight Board (“PCAOB”). Huron is not a law firm; it does not offer, and is not authorized to provide, legal advice or counseling in any jurisdiction. Huron is the trading name of Pope Woodhead & Associates Ltd.